CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156

Modify Date: 2025-08-26 16:28:57

CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 Structure
CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 structure
Common Name CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156
CAS Number 254110-79-7 Molecular Weight 302.93
Density N/A Boiling Point N/A
Molecular Formula TKSVY2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156


CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 corresponding to amino acids 148-156 of the BRLF1 protein. BRLF1 is a transcriptional activator that binds directly to a GC-rich motif present in some Epstein-Barr virus (EBV) lytic gene promoters[1].

 Names

Name CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156

  Biological Activity

Description CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156 corresponding to amino acids 148-156 of the BRLF1 protein. BRLF1 is a transcriptional activator that binds directly to a GC-rich motif present in some Epstein-Barr virus (EBV) lytic gene promoters[1].
Related Catalog
In Vitro Expression of the EBV immediate-early (IE) protein BRLF1 induces the lytic form of viral replication in most EBV-positive cell lines[1].
References

[1]. Darr CD, et al. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. J Virol. 2001 Jul;75(13):6135-42.

 Chemical & Physical Properties

Molecular Formula TKSVY2
Molecular Weight 302.93
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
CEF19, Epstein-Barr Virus latent NA-3A 458-466
157876-41-0
indolall
67801-36-9
methyl 2-[(2,2-dimethyl-1-oxopropyl)amino]benzoate
84540-62-5
2-Anthracenesulfonic acid, 8-[[4-(1,1-dimethylethyl)-2-sulfophenyl]amino]-9,10-dihydro-1-hydroxy-5-[(1-methylethyl)amino]-9,10-dioxo-, sodium salt
72828-68-3
5-Allyl-N-(2-hydroxy-1,1-dimethylethyl)-2-hydroxy-m-anisamide
26750-97-0
Influenza virus-IN-1
108729-21-1
Anti-virus agent 1
1911578-83-0
Herpes virus inhibitor 1
103424-73-3
Zika virus-IN-1
2527912-80-5
(E)-1-(3-(benzo[d][1,3]dioxol-5-yl)acryloyl)-N-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)piperidine-4-carboxamide
1334377-20-6
N-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-1-(2-(thiophen-2-yl)acetyl)piperidine-4-carboxamide
1334371-91-3
1-(4-(N,N-dimethylsulfamoyl)benzoyl)-N-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)piperidine-4-carboxamide
1334376-46-3
1-(furan-2-carbonyl)-N-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)piperidine-4-carboxamide
1334373-23-7
2-Bromo-3-sulfanylbenzaldehyde
2138235-18-2
N-((3-methyl-1,2,4-oxadiazol-5-yl)methyl)-1-(2-oxo-2H-chromene-3-carbonyl)piperidine-4-carboxamide
1334374-90-1
N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]-1-(5-nitrofuran-2-carbonyl)piperidine-4-carboxamide
1334373-15-7
1H-Pyrrole-3-carboxamide, N-[2-[4-(1H-pyrazol-1-yl)phenyl]ethyl]-
1333756-40-3
1-(2,5-dimethylfuran-3-carbonyl)-N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]piperidine-4-carboxamide
1334373-50-0
N-(2-butyl-2,3-dihydro-1H-isoindol-4-yl)-1-(prop-2-yn-1-yl)piperidine-4-carboxamide
1333617-56-3